Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-030277

Chief Commercial Officer sold 1,417 shares at an average $87.80 ($124,413)

  • Chief Commercial Officer acquired 100 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-08 Exercise or conversion : show line 1 in the form 10b5-1 +100 $16.14 $1,614 26,602 D
2024-03-08 Sale : show line 2 in the form 10b5-1 −100 $90.04 $9,004 26,502 D
2024-03-08 Sale : show line 3 in the form 10b5-1 −1,317 $87.63 $115,409 25,185 D
Open-market sales · 1,417 sh · avg $87.80 · $124,413

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-08 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −100 15,646 D
Loading xslF345X05/ownership.xml…